These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 31235175)

  • 21. Primary prevention with statins and incident diabetes in hypertensive patients at high cardiovascular risk.
    Izzo R; de Simone G; Trimarco V; Giudice R; De Marco M; Di Renzo G; De Luca N; Trimarco B
    Nutr Metab Cardiovasc Dis; 2013 Nov; 23(11):1101-6. PubMed ID: 23419735
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adoption of the 2013 American College of Cardiology/American Heart Association Cholesterol Management Guideline in Cardiology Practices Nationwide.
    Pokharel Y; Tang F; Jones PG; Nambi V; Bittner VA; Hira RS; Nasir K; Chan PS; Maddox TM; Oetgen WJ; Heidenreich PA; Borden WB; Spertus JA; Petersen LA; Ballantyne CM; Virani SS
    JAMA Cardiol; 2017 Apr; 2(4):361-369. PubMed ID: 28249067
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sex Differences in Cardiovascular Disease and Cardiovascular Risk Estimation in Patients With Type 1 Diabetes.
    Dei Cas A; Aldigeri R; Mantovani A; Masulli M; Palmisano L; Cavalot F; Bonomo K; Baroni MG; Cossu E; Cavallo G; Cimini FA; Buzzetti R; Mignogna C; Leonetti F; Bacci S; Trevisan R; Morieri ML; Pollis RM; Targher G; Vigili de Kreutzenberg S
    J Clin Endocrinol Metab; 2023 Aug; 108(9):e789-e798. PubMed ID: 36881927
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Arterial stiffness is highly correlated with the scores obtained from the Steno Type 1 Risk Engine in subjects with T1DM.
    Llauradó G; Cano A; Albert L; Ballesta S; Mazarico I; Luchtenberg MF; González-Sastre M; Megía A; Simó R; Vendrell J; González-Clemente JM
    PLoS One; 2019; 14(9):e0220206. PubMed ID: 31483791
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Under-prescription of statins in patients with non-alcoholic fatty liver disease.
    Del Ben M; Baratta F; Polimeni L; Pastori D; Loffredo L; Averna M; Violi F; Angelico F
    Nutr Metab Cardiovasc Dis; 2017 Feb; 27(2):161-167. PubMed ID: 27914698
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Utilization of lipid-modifying therapy and low-density lipoprotein cholesterol goal attainment in patients at high and very-high cardiovascular risk: Real-world evidence from Germany.
    März W; Dippel FW; Theobald K; Gorcyca K; Iorga ŞR; Ansell D
    Atherosclerosis; 2018 Jan; 268():99-107. PubMed ID: 29197254
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Initiation Patterns of Statins in the 2 Years After Release of the 2013 American College of Cardiology/American Heart Association (ACC/AHA) Cholesterol Management Guideline in a Large US Health Plan.
    Olufade T; Zhou S; Anzalone D; Kern DM; Tunceli O; Cziraky MJ; Willey VJ
    J Am Heart Assoc; 2017 May; 6(5):. PubMed ID: 28473405
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Individualized Risk Communication and Outreach for Primary Cardiovascular Disease Prevention in Community Health Centers: Randomized Trial.
    Persell SD; Brown T; Lee JY; Shah S; Henley E; Long T; Luther S; Lloyd-Jones DM; Jean-Jacques M; Kandula NR; Sanchez T; Baker DW
    Circ Cardiovasc Qual Outcomes; 2015 Nov; 8(6):560-6. PubMed ID: 26555123
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Contemporary Estimate of Total Mortality and Cardiovascular Disease Risk in Young Adults With Type 1 Diabetes: The Pittsburgh Epidemiology of Diabetes Complications Study.
    Miller RG; Mahajan HD; Costacou T; Sekikawa A; Anderson SJ; Orchard TJ
    Diabetes Care; 2016 Dec; 39(12):2296-2303. PubMed ID: 27654986
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Application of the 2014 NICE cholesterol guidelines in the English population: a cross-sectional analysis.
    Ueda P; Lung TW; Clarke P; Danaei G
    Br J Gen Pract; 2017 Sep; 67(662):e598-e608. PubMed ID: 28760741
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cardiovascular Risk Factors and Adherence to Cardiovascular Protection Practice Guidelines in Adults With Type 1 Diabetes: A BETTER Registry Cross-sectional Analysis.
    Madar H; Lalanne-Mistrih ML; Lebbar M; Wu Z; Robitaille Y; Pelletier J; Grou C; Brazeau AS; Rabasa-Lhoret R
    Can J Diabetes; 2023 Aug; 47(6):473-481.e1. PubMed ID: 37059389
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gender inequalities in cardiovascular risk factor assessment and management in primary healthcare.
    Hyun KK; Redfern J; Patel A; Peiris D; Brieger D; Sullivan D; Harris M; Usherwood T; MacMahon S; Lyford M; Woodward M
    Heart; 2017 Apr; 103(7):492-498. PubMed ID: 28249996
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Statin utilization and lipid goal attainment in high or very-high cardiovascular risk patients: Insights from Italian general practice.
    Arca M; Ansell D; Averna M; Fanelli F; Gorcyca K; Iorga ŞR; Maggioni AP; Paizis G; Tomic R; Catapano AL
    Atherosclerosis; 2018 Apr; 271():120-127. PubMed ID: 29499359
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of cardiovascular risk assessment tools and their guidelines in evaluation of 10-year CVD risk and preventive recommendations: A population based study.
    Motamed N; Rabiee B; Perumal D; Poustchi H; Miresmail SJ; Farahani B; Maadi M; Saeedian FS; Ajdarkosh H; Khonsari MR; Hemasi GR; Zamani F
    Int J Cardiol; 2017 Feb; 228():52-57. PubMed ID: 27863362
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Severe hypoglycemia and hypoglycemia awareness are associated with preclinical atherosclerosis in patients with type 1 diabetes without an estimated high cardiovascular risk.
    Mesa A; Giménez M; Perea V; Serés-Noriega T; Boswell L; Blanco J; Milad C; Pané A; Esmatjes E; Vinagre I; Conget I; Viñals C; Amor AJ
    Diabetes Metab Res Rev; 2024 Mar; 40(3):e3785. PubMed ID: 38436542
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of 3 risk estimators to guide initiation of statin therapy for primary prevention of cardiovascular disease.
    Ofori S; Dodiyi-Manuel S; Akpa MR
    J Clin Lipidol; 2017; 11(6):1441-1447. PubMed ID: 29050979
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adherence to guidelines to prevent cardiovascular diseases: The LifeLines cohort study.
    Balder JW; Scholtens S; de Vries JK; van Schie LM; Boekholdt SM; Hovingh GK; Kamphuisen PW; Kuivenhoven JA
    Neth J Med; 2015 Aug; 73(7):316-23. PubMed ID: 26314714
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Low use of statins for secondary prevention in primary care: a survey in a northern Swedish population.
    Nilsson G; Samuelsson E; Söderström L; Mooe T
    BMC Fam Pract; 2016 Aug; 17(1):110. PubMed ID: 27515746
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Guideline-Based Statin Eligibility, Coronary Artery Calcification, and Cardiovascular Events.
    Pursnani A; Massaro JM; D'Agostino RB; O'Donnell CJ; Hoffmann U
    JAMA; 2015 Jul; 314(2):134-41. PubMed ID: 26172893
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Population health impact of statin treatment in Canada.
    Hennessy DA; Tanuseputro P; Tuna M; Bennett C; Perez R; Shields M; Ko DT; Tu J; Manuel DG
    Health Rep; 2016 Jan; 27(1):20-8. PubMed ID: 26788719
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.